Salivary Bioscience Studies That Have Impact: Getting Back to Our ABCDs
Share Article
Since being funded in 2015, the Adolescent Brain and Cognitive Development (ABCD) Study has enrolled more than 10,000 children with the objective to study numerous facets of cognitive, social, emotional, and physical development over 10 years. This multi-site, nationwide epidemiologic study is the largest of its type and focus to date. Salimetrics’ saliva collection devices, protocols, and laboratory testing services play an important part in generating this study’s salivary bioscience data.
ABCD restarting its program is a strong indication that the research community as a whole is ready to get started again.
Salimetrics Launches Saliva Testing with Industry-Leading SARS-CoV-2 IgG Antibody Multiplex Assay Used in Vaccine Clinical Trials
Share Article
Salimetrics now offers multiplex testing for antibodies against SARS-CoV-2 Nucleocapsid, Spike 1, and Spike 1 Receptor Binding Domain (RBD) using a single, easy-to-collect saliva sample. Researchers now have unparalleled access to saliva collection devices and COVID-19 antibody saliva testing on a robust and validated platform.
This effort provides an unparalleled opportunity to reliably test saliva samples for antibodies to a combination of three SARS-CoV-2 antigens (Spike, N, RBD) in the same, easy to collect sample. CARLSBAD, Calif. (PRWEB) March 16, 2021 The Salimetrics SalivaLab R&D Testing facility has recently adapted and completed a fit-for-purpose validation of the industry-leading multiplex for the detection of IgG antibodies to SARS-CoV-2 Nucleocapsid, Spike 1